Skip to content

Drug interactions

Sotorasib + Tenofovir alafenamide

Severity: Moderate

Sotorasib and Tenofovir alafenamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sotorasib is a weak P-gp inhibitor and a CYP3A4 inducer. The in vivo effect on tenofovir alafenamide has not been well characterised, and exposure could change modestly.

What this interaction means in plain words

Sotorasib and Tenofovir alafenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sotorasib belongs to Oncology; Tenofovir alafenamide belongs to Anti Virals.

Evidence level: Low

Why it happens

Sotorasib modulates intestinal P-gp and induces CYP3A4, which could alter tenofovir alafenamide absorption and metabolism; the net effect is not established.

What to do

Monitor HIV or hepatitis B virologic response and renal function if the combination is needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sotorasib and Tenofovir alafenamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sotorasib with Tenofovir alafenamide?

MediHelp rates the interaction as moderate. Sotorasib and Tenofovir alafenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sotorasib is a weak P-gp inhibitor and a CYP3A4 inducer. The in vivo effect on tenofovir alafenamide has not been well characterised, and exposure could change modestly.

How serious is the interaction between Sotorasib and Tenofovir alafenamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor HIV or hepatitis B virologic response and renal function if the combination is needed.

What other medicines interact with Tenofovir alafenamide?

MediHelp also lists interactions of Tenofovir alafenamide with, for example, Apalutamide, Berotralstat, Danicopan. The full list is on the Tenofovir alafenamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in